Medline Inc.
For the period ended Mar 28, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 28, 2026 · Filed May 6, 2026
MDLN$40.91+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income
MEDLINE INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
| Three months ended | ||
|---|---|---|
| (in millions, except per share amounts) | March 28, 2026 | March 29, 2025 |
| Net sales | $7,352 | $6,644 |
| Cost of goods sold | 5,511 | 4,820 |
| Gross profit | 1,841 | 1,824 |
| Operating expense | ||
| Selling, general and administrative expenses | 1,228 | 1,070 |
| Amortization of intangible assets | 176 | 175 |
| Other operating expenses | 15 | 8 |
| Total operating expense | 1,419 | 1,253 |
| Operating income | 422 | 571 |
| Other expense | ||
| Interest expense, net | (136) | (210) |
| Other income, net | 1 | — |
| Foreign exchange gain (loss), net | 4 | (23) |
| Total other expense | (131) | (233) |
| Income before income taxes | 291 | 338 |
| Provision for income taxes | 52 | 16 |
| Net income | 239 | 322 |
| Net income attributable to noncontrolling interests | 110 | — |
| Net income attributable to Medline Inc. | $129 | $322 |
| Earnings per share attributable to Medline Inc. | ||
| Basic | $0.16 | N/A |
| Diluted | $0.16 | N/A |
| Weighted-average number of Class A common stock outstanding | ||
| Basic | 819 | N/A |
| Diluted | 825 | N/A |
| Other comprehensive loss, net of tax | ||
| Net unrealized loss on derivative instruments | (3) | (30) |
| Currency translation adjustment | (11) | 26 |
| Total other comprehensive loss, net of tax | (14) | (4) |
| Total comprehensive income | 225 | 318 |
| Comprehensive income attributable to noncontrolling interests | 105 | — |
| Comprehensive income attributable to Medline Inc. | $120 | $318 |
See notes to unaudited condensed consolidated financial statements.
7
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.